Laila Agrawal is a board-certified medical oncologist specializing in breast cancer. She has a sexual health clinic for women diagnosed with cancer at Norton Cancer Institute in Louisville, Kentucky. Dr. Agrawal earned her medical degree from Indiana University School of Medicine. She completed her internal medicine internship and residency at Barnes-Jewish Hospital at Washington University in St. Louis, followed by a hematology and oncology fellowship at Vanderbilt University School of Medicine. She is a fellow of the International Society for the Study of Women’s Sexual Health and serves on the board of directors of the Scientific Network on Female Sexual Health and Cancer and the Kentucky Society of Clinical Oncology. Dr. Agrawal is passionate about educating patients and medical professionals about sexual health for patients diagnosed with cancer. She has authored numerous articles and book chapters on this topic, and is a frequently invited speaker for medical conferences, patient support events, and podcasts.

Dr. Muna Al-Khaifi is a General Practitioner (GP) Oncologist at Mount Sinai Hospital in Toronto, where she serves as the Physician Lead of the Breast Diagnostic Clinic within the Department of Surgery. She is also an Onco-Menopause Specialist at the SHE-CAN (Sexual HEalth in breast CANcer) Clinic, Canada's first specialized clinic dedicated to the management of genitourinary syndrome of menopause in individuals with breast cancer. Dr. Al-Khaifi also works within the Cancer Survivorship Program at William Osler Health System, where she provides survivorship care for patients living with and beyond breast, skin, and gastrointestinal cancers.

In addition to her clinical roles at Mount Sinai, Dr. Al-Khaifi is an Assistant Professor in the Department of Family and Community Medicine at the University of Toronto. She is committed to advancing postgraduate medical education by developing innovative educational programs and fostering essential competencies such as empathy, cultural humility, and culturally safe care.

Previously, Dr. Al-Khaifi completed a Master of Public Health at the Dalla Lana School of Public Health, University of Toronto. She also founded and led the Breast Cancer Survivorship Program at Sunnybrook Health Sciences Centre, helping to establish comprehensive survivorship services for breast cancer patients.

Dr. Al-Khaifi is passionate about patient education, particularly in the field of breast cancer survivorship. She is dedicated to improving care for underserved and marginalized populations by examining how healthcare teams can better address the unique needs of women diagnosed with breast cancer. Her goal is to create healthcare environments that are culturally safe, inclusive, compassionate, and non-judgmental.

Dr. Jeanne Bouteaud is an obstetrician-gynecologist at CHUM. She completed her medical studies at McGill University and her residency at the University of Montreal. She completed her postdoctoral training in Mature Women’s Health under the supervision of Dr. Wendy Wolfman at Mount Sinai Hospital in Toronto. She specializes in the management of menopause and gynecological sequelae in cancer survivors. She also has an interest in the follow-up of patients with genetic mutations at high risk of gynecological cancer. She combines her subspecialty in gynecology with expertise in quality of care and completed a 2-year fellowship through the University of Toronto’s Centre for Quality and Safety of Care.

Dr. Christine Brezden-Masley is a practicing medical oncologist, Professor in the Department of Medicine’s Division of Medical Oncology at the University of Toronto’s Temerty Faculty of Medicine, Director of the Marvelle Koffler Breast Centre at Mount Sinai Hospital as well as the Medical Director of Cancer Program for Sinai Health System in Toronto, Canada. She is a senior scientist for the same Clinical Research Group at the Lunefeld-Tanenbaum Research Institute for Sinai Health System in Toronto, Canada.

Dr. Brezden-Masley is the founder of the COMET (Community Oncologists of Metropolitan Toronto) Clinical Trials Consortium, a web-based virtual network promoting cancer clinical trials throughout the Toronto region. She treats both breast and gastrointestinal (colorectal and gastric cancers) malignancies, which are her major areas of research interest. Her main area of clinical research is cardiotoxicity from cancer therapy and is currently the President of the Canadian Cardio-Oncology Network. She is also on the Board of Directors of ReThink Breast Cancer, a national advocacy and support network for young women with breast cancer and My Gut Feeling, a stomach cancer support network for patients, survivors, and caregivers.

As a breast oncologist, Dr. Comander has witnessed the struggles her patients face during and following completion of primary cancer treatment, and she is passionate about improving the overall health and well-being of breast cancer survivors through lifestyle interventions. In collaboration with Dr. Frates, she launched the PAVING the Path to Wellness Program lifestyle medicine program for breast cancer survivors. She has co-authored PAVING Your Path Through Breast Cancer and Beyond which focuses on the role of evidence-based lifestyle interventions for cancer survivors. Dr. Comander was the first oncologist to service on the Board of Directors of the American College of Lifestyle Medicine, and she was honored to be the first oncologist who has received the Fellows designation of the American College of Lifestyle Medicine.
Dr. Comander practices what she preaches, having run marathons, including 13 consecutive Boston Marathons to date, with the goal to improve the lives of those with a diagnosis of cancer. She views running marathons as a metaphor for life, and her favorite running mantra is “Every mile out there is a gift and every finish line is a gift” (Amby Burfoot, winner of the 1968 Boston Marathon).

Dr. Glass works on staff at Sunnybrook Health Sciences Centre and Women’s College Hospital, and as an Associate Professor at the University of Toronto. She joined the CReATe Fertility Centre, where she continues to work as Director of Fertility Preservation. Dr. Glass is currently the chair of the Fertility Preservation Special Interest Group of the Canadian Fertility and Andrology Society and previously served on the executive of the Fertility Preservation Special Interest Group of the American Society for Reproductive Medicine for five years (2009-2014). She has received a prestigious grant as a co-investigator from the Canadian Institutes of Health Research and Canadian Breast Cancer Foundation to study young women with breast cancer (RUBY Study). She previously sat on the Oncofertility Working Group for Adolescent and Young Adult Oncology, part of the Canadian Partnership Against Cancer. She currently sits on the Medical Advisory Panel for Fertile Future, where she was made their “Evening of Hope” Honouree in 2015 for her work helping young people with cancer.

Dr. Jasmin Hundal is a hematologist-oncologist whose work focuses on the intersection of cancer survivorship, cardiometabolic health, lifestyle medicine, and health equity. Her research explores how lifestyle behaviors, metabolic health, digital and wearable technologies, and emerging therapies such as GLP-1 receptor agonists can improve outcomes across the cancer continuum. She is particularly passionate about developing equitable and accessible approaches that integrate prevention and lifestyle-based care into oncology practice. Dr. Hundal completed her internal medicine residency and Master of Public Health at the University of Connecticut, followed by her Hematology-Oncology fellowship at the Cleveland Clinic. She is also active in the American College of Lifestyle Medicine.

Dr. Lisa Larkin is a board-certified internist and nationally recognized expert in women’s health with more than 35 years of clinical experience in both academic medicine and private practice. She previously served on the faculty at the University of Cincinnati College of Medicine in the Departments of Internal Medicine and Obstetrics and Gynecology, where she was Associate Professor, Division Director of Midlife Women’s Health and Primary Care, and founding Director of the UC Health Women’s Center, which she opened in 2013. In 2016, Dr. Larkin transitioned from academia to establish Concierge Medicine of Cincinnati (CMOC), a multispecialty internal medicine and women’s health practice that she continues to lead—now the region’s largest independent primary care practice. With a mission to improve women’s health nationally, she founded Ms.Medicine in 2019, a company working to improve the care of women by creating a national network of women’s health trained physicians advancing evidence-based, integrated primary and specialty women’s healthcare. Recognizing the critical gap in clinician education, she launched HERmedicine in 2024, a nonprofit organization dedicated to improving women’s health through education for both clinicians and consumers, and in 2025 she founded the OncoMenopause Consortium as a permanent initiative of HERmedicine focused on the intersection of cancer survivorship, menopause and midlife women’s health. Dr. Larkin’s areas of expertise include menopause management, sexual medicine, breast cancer risk assessment and prevention, hereditary cancer genetics, and cancer survivorship. She is a Fellow of the American College of Physicians and the International Society for the Study of Women’s Sexual Health and serves in leadership roles with The Menopause Society, ISSWSH, and the Global Women’s Health Academy.

Maryam Lustberg MD MPH is a breast medical oncologist. She is the co-chair of Symptom Intervention for the USA National Cancer Institute Alliance Clinical Trials and is the Past President of MASCC, an international organization devoted to improving cancer supportive care throughout the globe. Clinically she treats men and women with all stages of breast cancer with a focus on personalizing all aspects of cancer care incorporating latest advances in therapeutics as well as optimization of symptom management strategies and delivery of holistic person-centered care. Her research is centered on biomarkers of therapeutic response and toxicity as well as cancer treatment symptom management and survivorship care optimization.

Kira Page (she/her) is excited to bring her experience and skills to the task of transforming what is possible and available for breast cancer patients in Canada. Based in Montreal (Tio’Tia:ke), but hailing originally from the west coast, she herself had a de novo diagnosis of metastastic breast cancer at 32 years old. Kira brings a passion for community organizing and social justice work, particularly in the areas of migrant justice, intimate partner violence and the climate crisis. Her professional background is working with nonprofit and public service organizations to become healthier, more equitable, and more effective organizations. 

Jaclyn “Jackie” Piasta, DNP, WHNP-BC, MSCP is a nationally recognized leader in women’s and gender-related health, specializing in perimenopause, menopause, sexual health, and midlife metabolic care. She is a Doctor of Nursing Practice and a board-certified Women’s Health Nurse Practitioner, with certification as a Menopause Society Practitioner (MSCP) through The Menopause Society. Jackie maintains active membership in the International Society for the Study of Women’s Sexual Health, The National Association of Nurse Practitioners in Women’s Health, The International Menopause Society, American Association of Nurse Practitioners, Obesity Medicine Association, American College of Obstetricians and Gynecologists, and The Menopause Society.

She serves on the Medical Advisory Committee for the National Menopause Foundation and holds multiple national leadership roles, including service on the Advocacy Committee and Menopause Summit Planning Committee for NPWH, the Education Committee for The Menopause Society, and the Social Media Committee for ISSWSH. In recognition of her sustained contributions to the profession, Jackie was inducted as an inaugural Fellow of the National Association of Nurse Practitioners in Women’s Health in 2025, one of the organization’s highest honors. Jackie is a published author and a sought-after national speaker, presenting at major conferences on topics spanning menopause management, sexual health, obesity medicine, and clinician education.

Silvina Pugliese, MD, FAAD is a Clinical Associate Professor in the Division of Dermatology at NYU Grossman Long Island School of Medicine, where she also serves as Director of Inpatient Dermatology at NYU Langone Hospital - Long Island. Her clinical interests include inpatient dermatology, high-risk keratinocyte carcinomas, transplant dermatology, and oncodermatology, with a particular focus on cutaneous graft versus host disease and cancer survivorship.

William Raskin is a medical oncologist at the William Osler Health System and site lead for the breast and neuroendocrine tumor site groups. He is the current lead of the education program and former division head.He completed his undergraduate medical training at Mcmaster University, followed by Internal Medicine at Queen’s University and Medical Oncology at University of Toronto. He then worked as an associate medical oncologist at the Sunnybrook Health Sciences Centre in Toronto prior to working at William Osler. He clinical research includes multiple therapeutic clinical trials with interests in biomarker research as well as quality improvement and care delivery.

Jill Shainhouse, ND is a naturopathic doctor and founder of Insight Naturopathic Clinic in Midtown Toronto, with a clinical focus on integrative and supportive cancer care. Since 2004, she has worked alongside conventional oncology teams to provide individualized naturopathic support for patients throughout cancer treatment and survivorship. She also supervises a clinical internship observation program at Sunnybrook Hospital’s Louise Temerty Breast Cancer Centre. Her approach integrates evidence-informed nutrition, lifestyle medicine, natural therapies, and symptom management to support quality of life and overall well-being.

Robby Spring is an experienced professional in health innovation, commercialization, and public affairs, holding a BSc in Medical Biophysics, an MSc in Neuroscience, and an MHSc in Translational Research. Robby has over 15 years of experience across academia, hospital, government, and industry in the health and life sciences sector. Her recent experience as a breast cancer patient and care partner to her mom and sister, who also had breast cancer, has enriched her perspective on the healthcare system. Leveraging her professional background and personal insights, Robby is committed to making significant contributions as an advisor focused on patient engagement as well as improving and increasing the adoption of health technologies.

Dr. Joshua Wiley is a behavioural medicine researcher with a focus on understanding and improving sleep and mental health, particularly in people after a cancer diagnosis. Dr. Wiley is currently appointed as a senior research fellow (equivalent to Asst. Professor) at Monash University in the School of Psychological Sciences and Turner Institute for Brain and Mental Health (2016-present). He studied health psychology and behavioural medicine, completing his PhD at the University of California at Los Angeles in 2015. Subsequently, he trained in pragmatic randomised controlled trials (RCTs) through post doctoral with a primary care and prevention group.